Literature DB >> 9777320

Relationship between impaired glucose tolerance, non-insulin-dependent diabetes mellitus and obesity.

E Ferrannini1, S Camastra.   

Abstract

Plasma glucose concentration is the best predictor for the development of non-insulin-dependent diabetes mellitus (NIDDM). However, obesity is also a recognized risk factor for development of the disease, and is easier to track over time. Thus obesity could be of considerable clinical importance as a predictor of diabetes. Studies have shown that the degree of overweight, the change in weight and the duration of overweight are all separate predictors of diabetes. The British Regional Heart Study showed that an increasing body mass index (BMI) was associated with increased risk of developing diabetes, even at BMI values not considered obese. A separate study showed that weight gain increased the risk of diabetes independently of BMI, while weight loss decreased the risk. The duration of obesity was also an important factor in developing NIDDM. A long duration increased the risk of diabetes, irrespective of the final BMI value. The effects of obesity on insulin action have also been investigated. Studies have shown that insulin sensitivity is inversely related to insulin secretion, with a disproportionate increase in insulin secretion seen with decreasing sensitivity. A recent European study showed that the prevalence of both insulin hypersecretion and insulin resistance increased with increasing BMI. Thus, in obesity, higher insulin levels are necessary to maintain glucose tolerance, leading to increased stress on the beta-cells. In obese individuals, weight loss improved insulin sensitivity in proportion to the degree of weight loss, leading to decreased insulin secretion. Weight loss can therefore, at least in the short term, act to decrease the risk of developing diabetes by reducing insulin resistance, and thus relieving beta-cell stress, the factor ultimately responsible for hyperglycaemia in predisposed individuals.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9777320     DOI: 10.1046/j.1365-2362.1998.0280s2003.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  7 in total

1.  Higher branched-chain amino acid intake is associated with a lower prevalence of being overweight or obese in middle-aged East Asian and Western adults.

Authors:  Li-Qiang Qin; Pengcheng Xun; Deborah Bujnowski; Martha L Daviglus; Linda Van Horn; Jeremiah Stamler; Ka He
Journal:  J Nutr       Date:  2010-12-15       Impact factor: 4.798

Review 2.  The genetics of obesity and the metabolic syndrome.

Authors:  Keri L Monda; Kari E North; Steven C Hunt; D C Rao; Michael A Province; Aldi T Kraja
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2010-06       Impact factor: 2.895

Review 3.  Lessons in obesity from transgenic animals.

Authors:  J R S Arch
Journal:  J Endocrinol Invest       Date:  2002-11       Impact factor: 4.256

4.  Genetic and molecular insights into the role of PROX1 in glucose metabolism.

Authors:  Sophie Lecompte; Gianni Pasquetti; Xavier Hermant; Benjamin Grenier-Boley; Marcela Gonzalez-Gross; Stephan De Henauw; Denes Molnar; Peter Stehle; Laurent Béghin; Luis A Moreno; Philippe Amouyel; Jean Dallongeville; Aline Meirhaeghe
Journal:  Diabetes       Date:  2012-12-28       Impact factor: 9.461

Review 5.  Comorbidity-associated glutamine deficiency is a predisposition to severe COVID-19.

Authors:  Toshifumi Matsuyama; Steven K Yoshinaga; Kimitaka Shibue; Tak W Mak
Journal:  Cell Death Differ       Date:  2021-10-18       Impact factor: 15.828

6.  Diet normalization or caloric restriction as a preconception care strategy to improve metabolic health and oocyte quality in obese outbred mice.

Authors:  Anouk Smits; Waleed F A Marei; Diane De Neubourg; Jo L M R Leroy
Journal:  Reprod Biol Endocrinol       Date:  2021-11-04       Impact factor: 5.211

7.  Association of the NEGR1 rs2815752 with obesity and related traits in Pakistani females.

Authors:  Sobia Rana; Maha Mobin
Journal:  Ups J Med Sci       Date:  2020-05-18       Impact factor: 2.384

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.